Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 11/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | GGPS1 | O95749 | 6/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2962707 | 0.82 | FDPS (0.63) | FDPSGGPS1 | |
| SCHEMBL9929470 | 0.78 | FDPS (0.42) | FDPSCYP3A4L3MBTL1ALDH1A1CA2 | |
| SCHEMBL5548513 | 0.74 | CYP3A4 (0.46) | FDPSCYP3A4L3MBTL1ALDH1A1CA2 | |
| SCHEMBL5551648 | 0.73 | FDPS (0.63) | FDPSCYP3A4L3MBTL1ALDH1A1CA2 | |
| SCHEMBL2029824 | 0.72 | CA2 (0.44) | CYP3A4L3MBTL1ALDH1A1CA2TDP1 | |
| Etidronic Acid SCHEMBL10522451 | 0.72 | FDPS (0.44) | FDPSCYP3A4L3MBTL1ALDH1A1CA2 | |
| Etidronic Acid SCHEMBL10522231 | 0.72 | ALDH1A1 (0.61) | FDPSCYP3A4L3MBTL1ALDH1A1CA2 | |
| SCHEMBL8548552 | 0.72 | CYP3A4 (0.47) | FDPSCYP3A4L3MBTL1ALDH1A1CA2 | |
| SCHEMBL2469449 | 0.72 | CYP3A4 (0.47) | FDPSCYP3A4L3MBTL1ALDH1A1CA2 | |
| SCHEMBL2775263 | 0.72 | FDPS (0.50) | FDPSCYP3A4L3MBTL1ALDH1A1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1810975-B1 | METHOD FOR PRODUCING PHOSPHONATES HAVING AN ALCOHOLIC HYDROXY GROUP | DAIHACHI CHEM IND (JP) | 2013-07-31 | — | — | EP | disclosed |
| US-7772440-B2 | Process for preparing phosponates having alcoholic hydroxyl group | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2010-08-10 | — | — | US | disclosed |
| US-20090062568-A1 | PROCESS FOR PREPARING PHOSPHONATES HAVING ALCOHOLIC HYDROXYL GROUP | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-03-05 | — | — | US | disclosed |
| EP-1810975-A1 | METHOD FOR PRODUCING PHOSPHONATE HAVING ALCOHOLIC HYDROXY GROUP | DAIHACHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2007-07-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090062568-A1 | PROCESS FOR PREPARING PHOSPHONATES HAVING ALCOHOLIC HYDROXYL GROUP | PHOSPHO1, ADH1C, ADH1A | FDPS 528/4885CYP3A4 1057/4885L3MBTL1 4378/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.